Navigation Links
Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial
Date:3/16/2011

ohormone secreted by fat cells that plays a fundamental role in the regulation of energy metabolism and body weight. To date, more than 1,200 overweight or obese individuals have received metreleptin in clinical trials, several of which were 16 weeks or longer in duration.

About Amylin Pharmaceuticals, Inc.

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information on Amylin Pharmaceuticals is available at www.amylin.com.

About Takeda Pharmaceutical Company Limited

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.

Forward-Looking Statements Related to Amylin

This press release contains forward-looking statements about Amylin which involve risks and uncertainties. The actual results for Amylin could differ materially from those discussed due to a number of risks and uncertainties, including that the Company's obesity co-development and commercialization collaboration with Takeda will not achieve the results we expect; unexpected new data, safety and/or technical issues; our clinical trials
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
2. Amylin Pharmaceuticals to Present at the 2011 ISI Annual Conference
3. Amylin Pharmaceuticals Reports 2010 Financial Results
4. Amylin Pharmaceuticals to Webcast Year-End Financial Results
5. Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
6. Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy
7. Amylin Pharmaceuticals Reports Third Quarter Financial Results
8. Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference
9. Amylin, Lilly and Alkermes Announce Receipt of Complete Response Letter from FDA for BYDUREON™
10. Amylin Pharmaceuticals to Webcast Third Quarter Results
11. Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Conference 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... VILLAGE, Nev. , June 29, 2015  PDL ... it has entered into a credit agreement with CareView ... with up to $40 million of secured debt financing. ... industry focused on patient care monitoring. Under ... to $40 million of debt financing in two tranches ...
(Date:6/29/2015)... NESS ZIONA, Israel , ... Ltd. (Nasdaq: BVXV, TASE: BVXV) today announced positive preliminary ... M-001, BiondVax,s candidate for a universal influenza vaccine. In ... the ages of 50 to 65, followed by an ... 3 weeks later. M-001 was found to be safe ...
(Date:6/29/2015)... , June 29, 2015 DURECT ... James E. Brown , President and CEO, ... Conference on Wednesday, July 8 at 11:45 a.m. ... Le Parker Meridien Hotel in New York City.  ... may request a one-on-one meeting through the conference ...
Breaking Medicine Technology:PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 2BiondVax Presents BVX-006 Preliminary Phase II Results: the Universal Flu Vaccine at Higher Doses is Safe and Improves Immunogenicity in Older Adults 3DURECT to Present at the Cantor Fitzgerald Healthcare Conference 2
... risk of,stroke by 34% in patient with atrial fibrillation or ... adequately treated by antithrombotic ... a,post-hoc analysis of the data from the ATHENA study were ... Society of Cardiology,congress 2008, in Munich, Germany. Previous results from ...
... in Subjects with ALS, RICHMOND, Calif., Sept. 3 ... that it has opened a Phase,2 clinical trial (SB-509-801) ... progressive, degenerative motor-neuron disease for which there,are limited treatment ... an injectable formulation of a plasmid,encoding a zinc finger ...
Cached Medicine Technology:Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 2Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 3Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 4Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS) 5
(Date:6/30/2015)... Las Vegas, NV (PRWEB) , ... June 30, ... ... has recently returned to the U.S. after a 5-day tour in India. ... that are currently collaborating with Trivedi Master Wellness™ and Transformational Leader/Internationally ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... service and repair companies in San Diego. Bill Howe offers all employees ample ... through several organizations, but most notably through the local Plumbing-Heating-Cooling-Contractors of San Diego ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Some may ... – and the ongoing efforts of New York State Athletic Trainers’ Association (NYSATA) and ... NYSATA was recognized with two national awards, and a number of members also received ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... held October 28-31, 2015 at Disney’s Coronado Springs Resort in Lake Buena Vista, ... networking. Each year, this premiere event for psychiatric-mental health nursing draws more than ...
(Date:6/30/2015)... ... 2015 , ... Medflow, the leader in the ophthalmic EHR ... system from the company exclusively dedicated to helping eye care professionals for over ... solution combining modern cloud technology with Medflow’s proven expertise in the eye care ...
Breaking Medicine News(10 mins):Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 2Health News:Trivedi Global Inc. CEO Visits India to Finalize Science Projects to Create Anti-Aging, Overall Health and Probiotic Products with Help of a Multi-Billion Dollar Company 3Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 2Health News:Two Local San Diego Plumbers from Bill Howe Plumbing, Inc. Graduate from PHCC Academy 3Health News:NYSATA and Members Recognized with National Awards 2Health News:NYSATA and Members Recognized with National Awards 3Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 2Health News:American Psychiatric Nurses Association 29th Annual Conference: Continuing Education and Collaboration in Psychiatric-Mental Health and Nursing 3Health News:Medflow Launches MEDFLOW 2.0 EHR – The Cloud-Based Ophthalmology EHR 2
... The North Desert Village landscaping experiment was conducted in ... of this experiment were that the graduate student families ... and fertile lawns and ornamental bushes spend time together ... in a nearby cluster of six homes on native ...
... New Orleans – The manner with which an individual ... rather than the chronological age, say leading researchers in ... is all about handling stress well and having a ... of studies on how stress hormones affect the brain, ...
... H.Influenza could be virtually abolished in Africa by routinely ... from the Oxford University have shown in their research ... H. influenza Type b (Hib) significantly reduced invasive Hib ... their findings in the Journal of the American Medical ...
... the UN Food and Agriculture Organisation (FAO) and the World ... an early warning system in order to spread awareness of ... animals to humans. ,Such a system has become imperative ... with alarming frequency. "The spread of avian flu reinforces the ...
... can also cause problems in men, according to a new ... at the Telethon Institute for Child Health Research // said ... in baby boys was now important. ,"The common ... affects girls, and that the genetic flaw would be so ...
... Institute in Sweden haves shown that the nerve cells of the ... ,The researchers explained that in a human body most of the ... example the cells of the liver take an approximate of two ... however found in their studies that the cells of the brain ...
Cached Medicine News:Health News:Environmental Surrounding Affects Human Behaviour 2Health News:Studying the psycho neurobiology of aging 2Health News:Studying the psycho neurobiology of aging 3Health News:Researchers claim That Regular Use Of Hib Vaccine In Africa Could Eliminate H. Influenza totally. 2Health News:Researchers claim That Regular Use Of Hib Vaccine In Africa Could Eliminate H. Influenza totally. 3Health News:Rett Syndrome In Men? 2Health News:Studies Show That Brain Cells Do Not Regenerate But Remain The Same Throughout 2
... acetabular cup system has been designed to ... tri-spiked and cluster hole configurations. The objective ... micromotion on three primary modes: Tilt, migration ... features result in initial and long-term fixation. ...
Optimal solution for normal acetabulum....
Optimal solution for normal acetabulum....
Biopro rimmed acetabular is manufactured from titanium and is porous coated on the outside of its shell. The rimmed acetabular accommodates a polyethylene inert....
Medicine Products: